首页 > 最新文献

Current health sciences journal最新文献

英文 中文
Predictive Value of Pulmonary Involvement in Stroke Patients Co-Infected with COVID-19. 合并感染 COVID-19 的中风患者肺部受累的预测价值。
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.9
Elena Anca Pinosanu, Emilia Burada, Denisa Pirscoveanu, Madalina Aldea, Carmen Valeria Albu, Roxana Surugiu, Raluca Elena Sandu

In response to the intricate clinical challenges posed by the intersection of COVID-19 and acute ischemic stroke, the Neuropsychiatry Hospital of Craiova, Romania, initiated a comprehensive study. This research aims to unravel the impacts of pulmonary complications on ischemic stroke outcomes, comparing patients with concurrent SARS-CoV-2 infection to those without. The study integrates pulmonary assessments, acknowledging the significant role respiratory involvement plays in the progression and prognosis of stroke patients during the pandemic. By systematically examining individuals with both acute ischemic stroke and COVID-19, the study seeks to shed light on the complex interplay between cerebral and pulmonary health. The findings are expected to enhance patient care by informing clinical decisions and leading to more effective management approaches for stroke patients in the COVID-19 era.

为了应对 COVID-19 和急性缺血性中风交织在一起所带来的错综复杂的临床挑战,罗马尼亚克拉约瓦神经精神病医院启动了一项综合研究。这项研究旨在比较同时感染 SARS-CoV-2 和未感染 SARS-CoV-2 的患者,揭示肺部并发症对缺血性中风预后的影响。这项研究纳入了肺部评估,承认呼吸系统受累在大流行期间对中风患者的病情发展和预后所起的重要作用。通过对急性缺血性中风患者和 COVID-19 患者进行系统检查,该研究试图揭示大脑和肺部健康之间复杂的相互作用。研究结果有望为临床决策提供依据,并为 COVID-19 时代的中风患者提供更有效的管理方法,从而加强对患者的护理。
{"title":"Predictive Value of Pulmonary Involvement in Stroke Patients Co-Infected with COVID-19.","authors":"Elena Anca Pinosanu, Emilia Burada, Denisa Pirscoveanu, Madalina Aldea, Carmen Valeria Albu, Roxana Surugiu, Raluca Elena Sandu","doi":"10.12865/CHSJ.49.04.9","DOIUrl":"10.12865/CHSJ.49.04.9","url":null,"abstract":"<p><p>In response to the intricate clinical challenges posed by the intersection of COVID-19 and acute ischemic stroke, the Neuropsychiatry Hospital of Craiova, Romania, initiated a comprehensive study. This research aims to unravel the impacts of pulmonary complications on ischemic stroke outcomes, comparing patients with concurrent SARS-CoV-2 infection to those without. The study integrates pulmonary assessments, acknowledging the significant role respiratory involvement plays in the progression and prognosis of stroke patients during the pandemic. By systematically examining individuals with both acute ischemic stroke and COVID-19, the study seeks to shed light on the complex interplay between cerebral and pulmonary health. The findings are expected to enhance patient care by informing clinical decisions and leading to more effective management approaches for stroke patients in the COVID-19 era.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update in LV Only Fusion CRT Pacing: Annals and Future Perspectives. 仅左心室融合 CRT 起搏的最新进展:年鉴与未来展望
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.01
Andra Gurgu, Lucian Petrescu, Constantin Tudor Luca, Cristina Văcărescu, Georgică Târtea, Emilia-Violeta Goanță, Liviu Cirin, Dragoș Cozma

Triple-chamber cardiac devices are utilized for cardiac resynchronization therapy (CRT) and is the standard-of-care therapy for heart failure (HF) patients in the current guidelines. In the setting of biventricular (BIV) pacing it involves a mandatory implantation of right ventricular (RV) lead that allows simultaneous BIV pacing with 0 ms VV (ventricular to ventricular) interval. Nevertheless, it seems that response to CRT is not related to RV lead position. RV pacing is known for deleterious effects on RV/Left Ventricle (LV) function and should not be used in persons with normal atrioventricular conduction (AV) and sinus rhythm. As it compensates for the additional asynchrony induced by unnecessary stimulation of RV pacing, only pacing the left ventricle (LV) may result in improved cardiac resynchronization therapy (CRT) outcomes and a decrease in the number of individuals who do not respond to the procedure. Furthermore, leadless LV fusion CRT pacing without RV lead could be a potential CRT therapy alternative to BIV pacing in nonischemic heart failure patients with preserved AV conduction. The aim of our study is to made an update in cardiac resynchronization therapy with LV only fusion pacing.

三腔心脏设备用于心脏再同步化治疗(CRT),是现行指南中心力衰竭(HF)患者的标准治疗方法。在双心室(BIV)起搏的情况下,必须植入右心室(RV)导联,使双心室(BIV)起搏同时达到 0 毫秒 VV(心室到心室)间隔。然而,对 CRT 的反应似乎与 RV 导联位置无关。众所周知,RV 起搏会对 RV/左心室(LV)功能产生有害影响,因此不应用于房室传导(AV)和窦性心律正常的患者。由于只对左心室起搏可补偿因不必要的 RV 起搏刺激而引起的额外不同步,因此可改善心脏再同步化疗法(CRT)的疗效,并减少对手术无反应的人数。此外,在保留房室传导的非缺血性心衰患者中,不使用 RV 导联的无导联 LV 融合 CRT 起搏可能是 BIV 起搏的一种潜在 CRT 治疗替代方法。我们的研究旨在更新仅左心室融合起搏的心脏再同步疗法。
{"title":"Update in LV Only Fusion CRT Pacing: Annals and Future Perspectives.","authors":"Andra Gurgu, Lucian Petrescu, Constantin Tudor Luca, Cristina Văcărescu, Georgică Târtea, Emilia-Violeta Goanță, Liviu Cirin, Dragoș Cozma","doi":"10.12865/CHSJ.49.04.01","DOIUrl":"10.12865/CHSJ.49.04.01","url":null,"abstract":"<p><p>Triple-chamber cardiac devices are utilized for cardiac resynchronization therapy (CRT) and is the standard-of-care therapy for heart failure (HF) patients in the current guidelines. In the setting of biventricular (BIV) pacing it involves a mandatory implantation of right ventricular (RV) lead that allows simultaneous BIV pacing with 0 ms VV (ventricular to ventricular) interval. Nevertheless, it seems that response to CRT is not related to RV lead position. RV pacing is known for deleterious effects on RV/Left Ventricle (LV) function and should not be used in persons with normal atrioventricular conduction (AV) and sinus rhythm. As it compensates for the additional asynchrony induced by unnecessary stimulation of RV pacing, only pacing the left ventricle (LV) may result in improved cardiac resynchronization therapy (CRT) outcomes and a decrease in the number of individuals who do not respond to the procedure. Furthermore, leadless LV fusion CRT pacing without RV lead could be a potential CRT therapy alternative to BIV pacing in nonischemic heart failure patients with preserved AV conduction. The aim of our study is to made an update in cardiac resynchronization therapy with LV only fusion pacing.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Holographic Techniques as a Novel Method for Intervention Planning: A Tertiary Centres Experience. 全息技术作为干预规划的新方法:一个高等教育中心的经验。
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.15
Angelo Fabio D'Aiello, Ludovica Bognoni, Francesca Bevilacqua, Diana Gabriela Negura, Paolo Ferrero, Angelo Micheletti, Alessandro Giamberti, Sebastian Militaru, Constantin Militaru, Massimo Chessa

Advanced holographic visualization techniques are becoming increasingly important in clinical practice, not only for diagnostic purposes but also in the planning of interventional or surgical procedures. The traditional approach for visualizing anatomic structures is based on standard imaging modalities such as echocardiography, cardiac magnetic resonance (CMR) and cardiac CT scan (CCT) which, however, can only provide two-dimensional (2D) images thus limiting 3D perception. Many recent studies have shown that the use of 3D imaging modalities such as augmented reality, virtual reality, mixed reality and holography improve the short and long-term outcome of percutaneous or surgical procedures. In this article, we report our experience on the use of the hologram in different clinical scenarios and in the field of university education.

先进的全息可视化技术在临床实践中正变得越来越重要,不仅用于诊断目的,而且还用于规划介入或外科手术。传统的解剖结构可视化方法是基于标准成像模式,如超声心动图、心脏磁共振(CMR)和心脏 CT 扫描(CCT),但它们只能提供二维(2D)图像,因此限制了三维感知。最近的许多研究表明,使用三维成像模式,如增强现实、虚拟现实、混合现实和全息技术,可以改善经皮或外科手术的短期和长期效果。在本文中,我们将报告在不同临床场景和大学教育领域使用全息影像的经验。
{"title":"Holographic Techniques as a Novel Method for Intervention Planning: A Tertiary Centres Experience.","authors":"Angelo Fabio D'Aiello, Ludovica Bognoni, Francesca Bevilacqua, Diana Gabriela Negura, Paolo Ferrero, Angelo Micheletti, Alessandro Giamberti, Sebastian Militaru, Constantin Militaru, Massimo Chessa","doi":"10.12865/CHSJ.49.04.15","DOIUrl":"10.12865/CHSJ.49.04.15","url":null,"abstract":"<p><p>Advanced holographic visualization techniques are becoming increasingly important in clinical practice, not only for diagnostic purposes but also in the planning of interventional or surgical procedures. The traditional approach for visualizing anatomic structures is based on standard imaging modalities such as echocardiography, cardiac magnetic resonance (CMR) and cardiac CT scan (CCT) which, however, can only provide two-dimensional (2D) images thus limiting 3D perception. Many recent studies have shown that the use of 3D imaging modalities such as augmented reality, virtual reality, mixed reality and holography improve the short and long-term outcome of percutaneous or surgical procedures. In this article, we report our experience on the use of the hologram in different clinical scenarios and in the field of university education.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Neutrophil to Lymphocyte Ratio in the Assessment and Rehabilitation of Knee Osteoarthritis Patients. 中性粒细胞与淋巴细胞比率在膝骨关节炎患者评估和康复中的作用
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.10
Ovidiu-Florin Fugaru, Mircea-Sebastian Șerbănescu, Magdalena Rodica Trăistaru

Osteoarthritis (OA) is considered to be a real problem for many people. The last decade is characterized through an increased interest in using a non-specific, simply and readily available marker of inflammation-neutrophil to lymphocyte ratio (NLR)-to predict various chronic diseases (gastrointestinal and colorectal cancers, lung cancer, cardiovascular events, sarcoidosis, arthritis). The aim of our study is to establish the correlation between NLR and other parameters of clinical and functional status in KOA patients and to compare the NLR values before and after rehabilitation program. 90 patients, aged 40 to 82 years, diagnosed with mild (8 patients), moderate (70 patients) and severe (12 patients) KOA, in accordance with Kellgren and Lawrence score. Statistical assessment showed different values for the erythrocyte sedimentation (ESR) rate at 1-hour, Visual Analogue Scale (VAS), and Lequesne index in the studied group. NLR regression was significant for ESR at 1 and 2 hours. As an independent diagnostic marker, NLR has limited value, however it can be considered an inexpensive additional biomarker for the diagnosis of KOA and for monitoring the rehabilitation program.

骨关节炎(OA)被认为是许多人面临的现实问题。近十年来,人们越来越关注使用一种非特异性、简单易得的炎症标志物--中性粒细胞与淋巴细胞比值(NLR)--来预测各种慢性疾病(胃肠道癌和结肠直肠癌、肺癌、心血管疾病、肉样瘤病、关节炎)。我们的研究旨在建立 KOA 患者 NLR 与其他临床和功能状态参数之间的相关性,并比较康复计划前后的 NLR 值。根据 Kellgren 和 Lawrence 评分,90 名患者被诊断为轻度(8 名)、中度(70 名)和重度(12 名)KOA,年龄在 40 岁至 82 岁之间。统计评估显示,研究组的 1 小时红细胞沉降率(ESR)、视觉模拟量表(VAS)和勒克斯指数值各不相同。1 小时和 2 小时血沉的 NLR 回归显著。作为一种独立的诊断标志物,NLR 的价值有限,但它可被视为诊断 KOA 和监测康复计划的一种廉价的附加生物标志物。
{"title":"The Role of Neutrophil to Lymphocyte Ratio in the Assessment and Rehabilitation of Knee Osteoarthritis Patients.","authors":"Ovidiu-Florin Fugaru, Mircea-Sebastian Șerbănescu, Magdalena Rodica Trăistaru","doi":"10.12865/CHSJ.49.04.10","DOIUrl":"10.12865/CHSJ.49.04.10","url":null,"abstract":"<p><p>Osteoarthritis (OA) is considered to be a real problem for many people. The last decade is characterized through an increased interest in using a non-specific, simply and readily available marker of inflammation-neutrophil to lymphocyte ratio (NLR)-to predict various chronic diseases (gastrointestinal and colorectal cancers, lung cancer, cardiovascular events, sarcoidosis, arthritis). The aim of our study is to establish the correlation between NLR and other parameters of clinical and functional status in KOA patients and to compare the NLR values before and after rehabilitation program. 90 patients, aged 40 to 82 years, diagnosed with mild (8 patients), moderate (70 patients) and severe (12 patients) KOA, in accordance with Kellgren and Lawrence score. Statistical assessment showed different values for the erythrocyte sedimentation (ESR) rate at 1-hour, Visual Analogue Scale (VAS), and Lequesne index in the studied group. NLR regression was significant for ESR at 1 and 2 hours. As an independent diagnostic marker, NLR has limited value, however it can be considered an inexpensive additional biomarker for the diagnosis of KOA and for monitoring the rehabilitation program.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration. Aflibercept 与贝伐珠单抗作为老年性黄斑变性的一线疗法。
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.4
Mădălina-Casiana Palfi Salavat, Edward Paul Șeclăman, Andreea-Alexandra Mușat, Mădălina Borugă, Cristina Patoni, Marius-Nicolae Popescu, Oana Elena Teodorescu, Ovidiu Mușat, Stella Ioana Popescu Patoni

Background: AMD (age-related macular degeneration) is the main cause of central vision loss in the population over 60 years old. AMD does not affect peripheral vision and complete blindness does not occur, instead, central vision is affected both for distance and for near. The purpose of this study is to evaluate the neovascular form of AMD treatment and compare ocular and systemic effects after intravitreal injection of aflibercept, respectively after bevacizumab when administered in comparable dosages and regimens. We conducted a retrospective, single-center study from June 2021 to December 2022 and enrolled 20 patients with neovascular AMD who had not received any prior treatment for this condition. We randomly assigned them to two groups of 10: group one received aflibercept and group two received bevacizumab as intravitreal injections under aseptic conditions. We excluded 2 patients who did not meet the criteria and ended up with two groups of 9 patients who received monocular treatment. We gave the patients 3 monthly injections of anti-VEGF agent and followed them up at 1 month, 3 months, and 9 months after the treatment. We assessed their visual acuity, intraocular pressure and OCT appearance at each follow-up visit. The primary outcome was visual acuity. All 18 patients included in the study reported an improvement in visual acuity after the intervention. When comparing the two anti-VEGF agents, data revealed the effect of aflibercept was prompter and more long-lasting. Areas of retinal ischemia appeared in both cases. However, they were observed faster in the case of patients treated with aflibercept. Thus, neovascular AMD is a disease that occurs with age, it can be early detected by OCT and slowed the progression to central blindness with intravitreal treatment.

背景:老年黄斑变性(AMD)是造成 60 岁以上人群中心视力丧失的主要原因。黄斑变性不会影响周边视力,也不会导致完全失明,相反,中心视力会受到远近视力的影响。本研究的目的是评估新生血管性视网膜病变的治疗方法,并比较玻璃体内注射阿弗利百普和贝伐珠单抗后的眼部和全身疗效。我们在 2021 年 6 月至 2022 年 12 月期间开展了一项回顾性单中心研究,共招募了 20 名之前未接受过任何治疗的新生血管性黄斑变性患者。我们将他们随机分配到两组,每组 10 人:第一组接受阿夫利韦齐(aflibercept)治疗,第二组在无菌条件下接受贝伐单抗的玻璃体内注射。我们排除了 2 名不符合标准的患者,最终两组共 9 名患者接受了单眼治疗。我们每月为患者注射 3 次抗血管内皮生长因子药物,并在治疗后 1 个月、3 个月和 9 个月进行随访。每次随访时,我们都会对患者的视力、眼压和 OCT 外观进行评估。主要结果是视力。研究中的所有 18 名患者均报告称,干预后视力有所改善。在比较两种抗血管内皮生长因子药物时,数据显示,aflibercept 的疗效更迅速、更持久。两种药物都出现了视网膜缺血区。不过,使用阿弗利百普治疗的患者更快出现缺血区。因此,新生血管性黄斑变性是一种随着年龄增长而出现的疾病,它可以通过光学视网膜成像技术及早发现,并通过玻璃体内治疗延缓其发展为中心性失明。
{"title":"Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.","authors":"Mădălina-Casiana Palfi Salavat, Edward Paul Șeclăman, Andreea-Alexandra Mușat, Mădălina Borugă, Cristina Patoni, Marius-Nicolae Popescu, Oana Elena Teodorescu, Ovidiu Mușat, Stella Ioana Popescu Patoni","doi":"10.12865/CHSJ.49.04.4","DOIUrl":"10.12865/CHSJ.49.04.4","url":null,"abstract":"<p><strong>Background: </strong>AMD (age-related macular degeneration) is the main cause of central vision loss in the population over 60 years old. AMD does not affect peripheral vision and complete blindness does not occur, instead, central vision is affected both for distance and for near. The purpose of this study is to evaluate the neovascular form of AMD treatment and compare ocular and systemic effects after intravitreal injection of aflibercept, respectively after bevacizumab when administered in comparable dosages and regimens. We conducted a retrospective, single-center study from June 2021 to December 2022 and enrolled 20 patients with neovascular AMD who had not received any prior treatment for this condition. We randomly assigned them to two groups of 10: group one received aflibercept and group two received bevacizumab as intravitreal injections under aseptic conditions. We excluded 2 patients who did not meet the criteria and ended up with two groups of 9 patients who received monocular treatment. We gave the patients 3 monthly injections of anti-VEGF agent and followed them up at 1 month, 3 months, and 9 months after the treatment. We assessed their visual acuity, intraocular pressure and OCT appearance at each follow-up visit. The primary outcome was visual acuity. All 18 patients included in the study reported an improvement in visual acuity after the intervention. When comparing the two anti-VEGF agents, data revealed the effect of aflibercept was prompter and more long-lasting. Areas of retinal ischemia appeared in both cases. However, they were observed faster in the case of patients treated with aflibercept. Thus, neovascular AMD is a disease that occurs with age, it can be early detected by OCT and slowed the progression to central blindness with intravitreal treatment.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ELTD1 Review: New Regulator of Angiogenesis in Glioma. ELTD1 回顾:胶质瘤血管生成的新调节器
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.03
Iuliana Buzatu, Daniela Elise Tache, Elena Victoria Manea Carneluti, Ovidiu Zlatian

Glioblastoma (GBM) is a severe brain cancer in which angiogenesis is controlled by G protein-coupled receptors (GPCRs), such as Epidermal Growth Factor Latrophilin and seven transmembrane domain-containing protein 1 (ELTD1), which are crucial for tumor progression. ELTD1 is an understudied GPCR with a broad expression profile in various tissues, including the human brain, especially in the cerebral cortex. It plays a significant role in angiogenesis and tumorigenesis and is regulated by interconnected VEGF and DLL4/Notch pathways. ELTD1 also modulates the JAK/STAT3/HIF-1α signaling axis, affecting the response of cells to low-oxygen conditions and promoting cell proliferation. However, their specific ligands and functional mechanisms remain unclear. ELTD1 expression is associated with different outcomes in various cancers. For example, in GBM, higher ELTD1 levels are linked to more mature and less leaky blood vessels, potentially enhancing drug delivery and therapeutic success. It also has divergent prognostic implications in renal, ovarian, and colorectal cancer. Additionally, ELTD1 overexpression in central nervous system endothelial cells suggests that it is a potential biomarker for multiple sclerosis. Therapeutically, blocking ELTD1 inhibits vessel formation, possibly slowing tumor growth. Initial therapies used polyclonal antibodies, but the shift has been towards more targeted monoclonal antibodies, particularly in preclinical glioma models. This review aimed to translate these insights into effective clinical treatments. However, several gaps remain in our knowledge regarding ELTD1 ligands and their potential involvement in other physiological or pathological processes that future research can address to elucidate the role of ELTD1 in cancer, through angiogenesis and other intracellular pathways.

胶质母细胞瘤(GBM)是一种严重的脑癌,其血管生成受 G 蛋白偶联受体(GPCR)控制,如表皮生长因子嗜铅蛋白(Epidermal Growth Factor Latrophilin)和含七跨膜域蛋白 1(ELTD1),它们对肿瘤的进展至关重要。ELTD1 是一种未被充分研究的 GPCR,在各种组织中都有广泛的表达,包括人脑,尤其是大脑皮层。它在血管生成和肿瘤发生过程中发挥着重要作用,并受到相互关联的血管内皮生长因子和 DLL4/Notch 通路的调控。ELTD1 还能调节 JAK/STAT3/HIF-1α 信号轴,影响细胞对低氧条件的反应并促进细胞增殖。然而,它们的具体配体和功能机制仍不清楚。ELTD1 的表达与各种癌症的不同结果有关。例如,在脑胶质瘤中,较高的ELTD1水平与更成熟、渗漏较少的血管有关,可能会促进药物输送和治疗的成功。它对肾癌、卵巢癌和结直肠癌的预后也有不同的影响。此外,ELTD1 在中枢神经系统内皮细胞中的过度表达表明,它是多发性硬化症的潜在生物标志物。在治疗上,阻断 ELTD1 可抑制血管的形成,从而可能减缓肿瘤的生长。最初的疗法使用多克隆抗体,但现在已转向更具针对性的单克隆抗体,特别是在临床前胶质瘤模型中。本综述旨在将这些见解转化为有效的临床治疗方法。然而,我们对ELTD1配体及其可能参与的其他生理或病理过程的认识仍存在一些空白,未来的研究可以通过血管生成和其他细胞内途径来阐明ELTD1在癌症中的作用。
{"title":"ELTD1 Review: New Regulator of Angiogenesis in Glioma.","authors":"Iuliana Buzatu, Daniela Elise Tache, Elena Victoria Manea Carneluti, Ovidiu Zlatian","doi":"10.12865/CHSJ.49.04.03","DOIUrl":"10.12865/CHSJ.49.04.03","url":null,"abstract":"<p><p>Glioblastoma (GBM) is a severe brain cancer in which angiogenesis is controlled by G protein-coupled receptors (GPCRs), such as Epidermal Growth Factor Latrophilin and seven transmembrane domain-containing protein 1 (ELTD1), which are crucial for tumor progression. ELTD1 is an understudied GPCR with a broad expression profile in various tissues, including the human brain, especially in the cerebral cortex. It plays a significant role in angiogenesis and tumorigenesis and is regulated by interconnected VEGF and DLL4/Notch pathways. ELTD1 also modulates the JAK/STAT3/HIF-1α signaling axis, affecting the response of cells to low-oxygen conditions and promoting cell proliferation. However, their specific ligands and functional mechanisms remain unclear. ELTD1 expression is associated with different outcomes in various cancers. For example, in GBM, higher ELTD1 levels are linked to more mature and less leaky blood vessels, potentially enhancing drug delivery and therapeutic success. It also has divergent prognostic implications in renal, ovarian, and colorectal cancer. Additionally, ELTD1 overexpression in central nervous system endothelial cells suggests that it is a potential biomarker for multiple sclerosis. Therapeutically, blocking ELTD1 inhibits vessel formation, possibly slowing tumor growth. Initial therapies used polyclonal antibodies, but the shift has been towards more targeted monoclonal antibodies, particularly in preclinical glioma models. This review aimed to translate these insights into effective clinical treatments. However, several gaps remain in our knowledge regarding ELTD1 ligands and their potential involvement in other physiological or pathological processes that future research can address to elucidate the role of ELTD1 in cancer, through angiogenesis and other intracellular pathways.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated with Stroke in Atrial Fibrillation. A Retrospective Study. 心房颤动患者中风的相关因素。回顾性研究。
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.13
Ciprian Rachieru, Daniel-Florin Lighezan, Lucian Petrescu, Elena-Anca Tartea, Emilia Violeta Goanta, Roxana Buzas, Dragos Cozma

Aim: The aim of our study was to retrospectively evaluate known factors such as CHA2DS2-VASc, but, also, new factors (such as left atrial remodeling), associated with the development of stroke in patients with atrial fibrillation (AFi).

Material and methods: We performed a retrospective study in which 251 patients with AFi were included. 47 patients had an ischemic stroke before the diagnosis of AFi, at the time of diagnosis or after AFi was diagnosed. The CHA2DS2-VASc score was analyzed for all patients together with other left atrial remodeling parameters.

Results: We observed that among the patients with ischemic stroke approximately 61.70% were over 72.5 years old compared to those without stroke who presented this age in a proportion of only 44.61% (OR=2.001, P=0.0367). The CHA2DS2-VASc score had the greatest statistical impact for stroke, as expected. Patients with a CHA2DS2-VASc score >4.5 presented stroke in a proportion of 87.23% compared to CHA2DS2-VASc <4.5 who had stroke only in a proportion of 12.77% (OR=11.51, P=<0.0001). Regarding left atrial remodeling parameters, low LA ejection fraction was associated with a high percentage of stroke among patients (61.70%) compared to those with LA EF>34.5% who had stroke only in a percentage of 38.30% (OR= 2.124, P=0.0238).

Conclusions: Although the CHA2DS2-VASc score remains a good factor for predicting the association of AFi with ischemic stroke, echocardiographic parameters for the evaluation of the left atrium can be used as new risk factors for predicting the occurrence of ischemic stroke in patients with AFi.

目的:我们的研究旨在回顾性评估与心房颤动(AFi)患者卒中发生相关的已知因素(如 CHA2DS2-VASc)以及新因素(如左心房重塑):我们进行了一项回顾性研究,共纳入 251 名心房颤动患者。47名患者在确诊心房颤动前、确诊时或确诊后发生过缺血性脑卒中。我们对所有患者的 CHA2DS2-VASc 评分和其他左心房重塑参数进行了分析:我们观察到,在缺血性脑卒中患者中,约 61.70% 的患者年龄超过 72.5 岁,而无脑卒中患者中这一年龄段的比例仅为 44.61%(OR=2.001,P=0.0367)。正如预期的那样,CHA2DS2-VASc 评分对中风的统计影响最大。CHA2DS2-VASc 评分大于 4.5 分的患者中风比例为 87.23%,而 CHA2DS2-VASc 评分为 34.5 分的患者中风比例仅为 38.30%(OR= 2.124,P=0.0238):尽管CHA2DS2-VASc评分仍是预测AFi与缺血性中风相关性的良好因素,但评估左心房的超声心动图参数可作为预测AFi患者发生缺血性中风的新风险因素。
{"title":"Factors Associated with Stroke in Atrial Fibrillation. A Retrospective Study.","authors":"Ciprian Rachieru, Daniel-Florin Lighezan, Lucian Petrescu, Elena-Anca Tartea, Emilia Violeta Goanta, Roxana Buzas, Dragos Cozma","doi":"10.12865/CHSJ.49.04.13","DOIUrl":"10.12865/CHSJ.49.04.13","url":null,"abstract":"<p><strong>Aim: </strong>The aim of our study was to retrospectively evaluate known factors such as CHA2DS2-VASc, but, also, new factors (such as left atrial remodeling), associated with the development of stroke in patients with atrial fibrillation (AFi).</p><p><strong>Material and methods: </strong>We performed a retrospective study in which 251 patients with AFi were included. 47 patients had an ischemic stroke before the diagnosis of AFi, at the time of diagnosis or after AFi was diagnosed. The CHA2DS2-VASc score was analyzed for all patients together with other left atrial remodeling parameters.</p><p><strong>Results: </strong>We observed that among the patients with ischemic stroke approximately 61.70% were over 72.5 years old compared to those without stroke who presented this age in a proportion of only 44.61% (OR=2.001, P=0.0367). The CHA2DS2-VASc score had the greatest statistical impact for stroke, as expected. Patients with a CHA2DS2-VASc score >4.5 presented stroke in a proportion of 87.23% compared to CHA2DS2-VASc <4.5 who had stroke only in a proportion of 12.77% (OR=11.51, P=<0.0001). Regarding left atrial remodeling parameters, low LA ejection fraction was associated with a high percentage of stroke among patients (61.70%) compared to those with LA EF>34.5% who had stroke only in a percentage of 38.30% (OR= 2.124, P=0.0238).</p><p><strong>Conclusions: </strong>Although the CHA2DS2-VASc score remains a good factor for predicting the association of AFi with ischemic stroke, echocardiographic parameters for the evaluation of the left atrium can be used as new risk factors for predicting the occurrence of ischemic stroke in patients with AFi.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Attitudes Toward Influenza Vaccination: Insights from a Romanian Family Medicine Patient Population. 了解人们对接种流感疫苗的态度:来自罗马尼亚家庭医学患者群体的见解。
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.6
Claudia Monica Danilescu, Virginia Maria Radulescu, Ancuta Roxana Delureanu, Mihail Cristian Pirlog

Introduction: Influenza represents a global respiratory virus infection with significant individual and societal implications, leading to considerable economic burdens and substantial mortality rates. Vaccine hesitancy, characterized by delays or refusals despite vaccine availability, presents a growing challenge in achieving adequate vaccination rates globally.

Aim: This study aimed to assess the attitudes of Romanian general practitioners' patients toward influenza vaccination during the recommended immunization period.

Materials and methods: A prospective multi-centered study involving 319 patients across five Family Medicine Offices in Romania was conducted. Participants completed a 12-item Vaccination Attitudes Examination (VAX) scale, assessing factors influencing vaccine acceptance. Statistical analyses were performed to evaluate the impact of demographic variables and attitudes toward vaccination.

Results: The study revealed significant variations in attitudes influencing influenza vaccine acceptance. Trust in vaccine benefits and confidence in natural immunity emerged as primary motivators for vaccine acceptance/denial, whereas concerns about commercial profiteering held lesser importance. Gender and residential environment impacted specific attitudes toward vaccination, while factors such as education and employment status did not significantly influence vaccine acceptance.

Discussion: The study underscores the critical role of trust in vaccine benefits as a primary driver for vaccine acceptance, diverging from prevalent conspiracy theories. While gender and residential environment influenced attitudes toward vaccination, education and employment status did not exhibit significant correlations with vaccine acceptance.

Conclusions: Understanding public attitudes toward vaccination is crucial in designing effective public health strategies. This study emphasizes the importance of trust in vaccine benefits in driving vaccine acceptance, offering insights to enhance vaccination initiatives regionally.

导言:流感是一种全球性的呼吸道病毒感染,对个人和社会都有重大影响,会造成巨大的经济负担和高死亡率。在全球范围内,疫苗接种率的提高面临着越来越大的挑战。目的:本研究旨在评估罗马尼亚全科医生的病人在建议的免疫接种期内对流感疫苗接种的态度:我们开展了一项前瞻性多中心研究,涉及罗马尼亚 5 家全科诊所的 319 名患者。参与者填写了一份由 12 个项目组成的疫苗接种态度量表 (VAX),以评估影响疫苗接受度的因素。研究还进行了统计分析,以评估人口统计学变量和疫苗接种态度的影响:研究显示,影响流感疫苗接受度的态度存在明显差异。对疫苗益处的信任和对自然免疫的信心是接受/拒绝接受疫苗的主要动机,而对商业暴利的担忧则不那么重要。性别和居住环境对疫苗接种的具体态度有影响,而教育和就业状况等因素对疫苗接受度的影响不大:讨论:这项研究强调了对疫苗益处的信任作为疫苗接受度主要驱动因素的关键作用,这与流行的阴谋论不同。虽然性别和居住环境影响着人们对疫苗接种的态度,但教育程度和就业状况与疫苗接受度并无明显关联:了解公众对疫苗接种的态度对于设计有效的公共卫生策略至关重要。这项研究强调了对疫苗益处的信任在推动疫苗接受度方面的重要性,为加强地区疫苗接种计划提供了启示。
{"title":"Understanding Attitudes Toward Influenza Vaccination: Insights from a Romanian Family Medicine Patient Population.","authors":"Claudia Monica Danilescu, Virginia Maria Radulescu, Ancuta Roxana Delureanu, Mihail Cristian Pirlog","doi":"10.12865/CHSJ.49.04.6","DOIUrl":"10.12865/CHSJ.49.04.6","url":null,"abstract":"<p><strong>Introduction: </strong>Influenza represents a global respiratory virus infection with significant individual and societal implications, leading to considerable economic burdens and substantial mortality rates. Vaccine hesitancy, characterized by delays or refusals despite vaccine availability, presents a growing challenge in achieving adequate vaccination rates globally.</p><p><strong>Aim: </strong>This study aimed to assess the attitudes of Romanian general practitioners' patients toward influenza vaccination during the recommended immunization period.</p><p><strong>Materials and methods: </strong>A prospective multi-centered study involving 319 patients across five Family Medicine Offices in Romania was conducted. Participants completed a 12-item Vaccination Attitudes Examination (VAX) scale, assessing factors influencing vaccine acceptance. Statistical analyses were performed to evaluate the impact of demographic variables and attitudes toward vaccination.</p><p><strong>Results: </strong>The study revealed significant variations in attitudes influencing influenza vaccine acceptance. Trust in vaccine benefits and confidence in natural immunity emerged as primary motivators for vaccine acceptance/denial, whereas concerns about commercial profiteering held lesser importance. Gender and residential environment impacted specific attitudes toward vaccination, while factors such as education and employment status did not significantly influence vaccine acceptance.</p><p><strong>Discussion: </strong>The study underscores the critical role of trust in vaccine benefits as a primary driver for vaccine acceptance, diverging from prevalent conspiracy theories. While gender and residential environment influenced attitudes toward vaccination, education and employment status did not exhibit significant correlations with vaccine acceptance.</p><p><strong>Conclusions: </strong>Understanding public attitudes toward vaccination is crucial in designing effective public health strategies. This study emphasizes the importance of trust in vaccine benefits in driving vaccine acceptance, offering insights to enhance vaccination initiatives regionally.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Pain after Inguinal Hernia Repair Using the Tension-Free Lichtenstein Procedure: A Retrospective Study. 使用无张力 Lichtenstein 手术进行腹股沟疝修补术后的疼痛:回顾性研究
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.7
Marian Răcăreanu, Silviu-Daniel Preda, Anamaria Predoi, Sapalidis Konstantinos, Tudor Bratiloveanu, Gabriel Florin Răzvan Mogoș, Adrian Dobrinescu, Sandu Râmboiu, Dragoș Mărgăritescu, Dan Cârțu, Valeriu Șurlin

Inguinal hernia surgery is a constantly evolving field, with ongoing research efforts aimed at enhancing surgical techniques and outcomes for patients. This retrospective study conducted between 2015 and 2020 in the First Surgical Clinic of Craiova Emergency Clinical Hospital focused on the occurrence and characteristics of postoperative pain following inguinal hernia repair using the tension-free Lichtenstein procedure. A total of 178 patients were included in the study, with 16.85% reporting postoperative pain. The average pain intensity was 6.4 on a scale of 1 to 10. Patients described the pain as numbness, burning sensation, stinging, pressure, and tingling sensations. Notably, 50% of patients reported pain related to weather changes. While the study explored potential relationships between patient demographics, hernia type, and postoperative pain, no statistically significant associations were found. Approximately 20% of patients with postoperative pain reported adverse effects on their work, and 10% used analgesics for pain management. This study highlights the multifaceted nature of postoperative pain following inguinal hernia repair, emphasizing the need for further research to identify individual risk factors and adherence to international guidelines for hernia management. The findings also underscore the importance of effective pain management strategies to improve patient comfort and quality of life post-surgery.

腹股沟疝手术是一个不断发展的领域,目前正在进行的研究旨在提高手术技术和患者的治疗效果。这项回顾性研究于 2015 年至 2020 年期间在克拉约瓦急诊临床医院第一外科诊所进行,重点研究了使用无张力 Lichtenstein 手术进行腹股沟疝修补术后疼痛的发生率和特点。共有 178 名患者参与了这项研究,其中 16.85% 的患者报告了术后疼痛。平均疼痛强度为 6.4(1 至 10 分)。患者将疼痛描述为麻木感、烧灼感、刺痛感、压迫感和刺痛感。值得注意的是,50% 的患者表示疼痛与天气变化有关。虽然该研究探讨了患者人口统计学特征、疝气类型和术后疼痛之间的潜在关系,但没有发现有统计学意义的关联。约 20% 的术后疼痛患者报告说他们的工作受到了不良影响,10% 的患者使用止痛药来缓解疼痛。这项研究突出了腹股沟疝修补术后疼痛的多面性,强调了进一步研究确定个体风险因素和遵守国际疝管理指南的必要性。研究结果还强调了有效的疼痛管理策略对提高患者舒适度和术后生活质量的重要性。
{"title":"Postoperative Pain after Inguinal Hernia Repair Using the Tension-Free Lichtenstein Procedure: A Retrospective Study.","authors":"Marian Răcăreanu, Silviu-Daniel Preda, Anamaria Predoi, Sapalidis Konstantinos, Tudor Bratiloveanu, Gabriel Florin Răzvan Mogoș, Adrian Dobrinescu, Sandu Râmboiu, Dragoș Mărgăritescu, Dan Cârțu, Valeriu Șurlin","doi":"10.12865/CHSJ.49.04.7","DOIUrl":"10.12865/CHSJ.49.04.7","url":null,"abstract":"<p><p>Inguinal hernia surgery is a constantly evolving field, with ongoing research efforts aimed at enhancing surgical techniques and outcomes for patients. This retrospective study conducted between 2015 and 2020 in the First Surgical Clinic of Craiova Emergency Clinical Hospital focused on the occurrence and characteristics of postoperative pain following inguinal hernia repair using the tension-free Lichtenstein procedure. A total of 178 patients were included in the study, with 16.85% reporting postoperative pain. The average pain intensity was 6.4 on a scale of 1 to 10. Patients described the pain as numbness, burning sensation, stinging, pressure, and tingling sensations. Notably, 50% of patients reported pain related to weather changes. While the study explored potential relationships between patient demographics, hernia type, and postoperative pain, no statistically significant associations were found. Approximately 20% of patients with postoperative pain reported adverse effects on their work, and 10% used analgesics for pain management. This study highlights the multifaceted nature of postoperative pain following inguinal hernia repair, emphasizing the need for further research to identify individual risk factors and adherence to international guidelines for hernia management. The findings also underscore the importance of effective pain management strategies to improve patient comfort and quality of life post-surgery.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoexpression of Mismatch Repair Proteins in a Cohort of Colorectal Cancer Patients. 错配修复蛋白在结直肠癌患者群中的免疫表达
Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.11
Alina Elena Ciobanu, Cristina Maria Marginean, Cristian Mesina, Tudor-Adrian Balseanu, Daniela Ciobanu, Mirela Marinela Florescu

One of the molecular routes of colorectal carcinogenesis is the lack of mismatch repair (MMR) proteins, which may have substantial clinical consequences in predicting therapy success. This study aimed to analyze the expression of the MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), and MutS homolog 6 (MSH6) in a cohort of 91 colorectal cancer (CRC) patients, and to evaluate the relationship between patient clinicopathological characteristics and immunoexpression of these biomarkers. In this study, we obtained the highest scores of the MLH1 immunoexpression in non-mucinous tumors, moderately differentiated lesions, and in stage IV. The highest values of the MSH2 and MSH6 scores were observed in mucinous tumors, and poorly differentiated lesions, in stages II-III, and stages III-IV, respectively. To improve the stratification criteria for targeted oncological therapy and to predict patient outcomes, markers used may help evaluate the aggressiveness of lesions.

错配修复(MMR)蛋白的缺乏是结直肠癌发生的分子途径之一,这可能对预测治疗成功率产生重大临床影响。本研究旨在分析91例结直肠癌(CRC)患者中MutL同源物1(MLH1)、MutS同源物2(MSH2)和MutS同源物6(MSH6)的表达情况,并评估患者临床病理特征与这些生物标志物的免疫表达之间的关系。在这项研究中,我们发现非黏液性肿瘤、中度分化病变和 IV 期患者的 MLH1 免疫表达得分最高。MSH2和MSH6的最高值分别出现在粘液性肿瘤、分化不良病变、II-III期和III-IV期。为了改进肿瘤靶向治疗的分层标准并预测患者的预后,所使用的标记物可能有助于评估病变的侵袭性。
{"title":"Immunoexpression of Mismatch Repair Proteins in a Cohort of Colorectal Cancer Patients.","authors":"Alina Elena Ciobanu, Cristina Maria Marginean, Cristian Mesina, Tudor-Adrian Balseanu, Daniela Ciobanu, Mirela Marinela Florescu","doi":"10.12865/CHSJ.49.04.11","DOIUrl":"10.12865/CHSJ.49.04.11","url":null,"abstract":"<p><p>One of the molecular routes of colorectal carcinogenesis is the lack of mismatch repair (MMR) proteins, which may have substantial clinical consequences in predicting therapy success. This study aimed to analyze the expression of the MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), and MutS homolog 6 (MSH6) in a cohort of 91 colorectal cancer (CRC) patients, and to evaluate the relationship between patient clinicopathological characteristics and immunoexpression of these biomarkers. In this study, we obtained the highest scores of the MLH1 immunoexpression in non-mucinous tumors, moderately differentiated lesions, and in stage IV. The highest values of the MSH2 and MSH6 scores were observed in mucinous tumors, and poorly differentiated lesions, in stages II-III, and stages III-IV, respectively. To improve the stratification criteria for targeted oncological therapy and to predict patient outcomes, markers used may help evaluate the aggressiveness of lesions.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current health sciences journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1